V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) Protein

Name: V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2)

Synonyme: Neu, HER2, HER-2, c-neu, Erbb-2, c-erbB2, mKIAA3023, NEU, NGL, TKR1, CD340, HER-2/neu

Protein-Typ: Recombinant

Biologische Aktivität: Active

Applikation: Enzymaktivitätsmessung (EAA)

Produktnummer: ABIN411967

Produktbeschreibung

Gen-ID: 44428

Beschreibung: Recombinant human HER2 (676-end) was expressed by baculovirus in Sf9 insect cells using a N-terminal GST tag. Gene Aliases ERBB2, NEU, NGL, TKR1, c-erb B2

Anwendungen

Applikationshinweise: Note: these are suggested working dilutions and it is recommended that the researcher perform a serial dilution of Active HCK for optimal results). [ 32 P]-ATP Assay Cocktail Prepare 250μM [ 32 P]-ATP Assay Cocktail in a designated radioactive working area by adding the following components: 150μl of 10mM ATP Stock Solution, 100μl [ 32P ]- ATP (1mCi/100μl), 5.75ml of Kinase Assay Buffer. Store 1ml aliquots at –20 °C. Kinase Dilution Buffer, pH 7.2 Kinase Assay Buffer II diluted at a 1:4 ratio (5X dilution) with 50 ng/μl BSA solution. 10mM ATP Stock Solution Prepare ATP stock solution by dissolving 55mg of ATP in 10ml of Kinase Assay Buffer. Store 200μl aliquots at –20 °C. Kinase Assay Buffer II, pH 7.2 Buffer components: 25mM MOPS, 12.5mM beta-glycerol-phosphate, 20mM MgC1 2 , 25mM MnC1 2 , 5mM EGTA, 2mM EDTA. Add 0.25mM DTT to Kinase Assay Buffer prior to use. Substrate Poly (Glu:Tyr, 4:1) synthetic peptide substrate diluted in distilled H 2 O to a final concentration of 1mg/ml. Assay Protocol Step 1. Thaw [ 32 P]-ATP Assay Cocktail in shielded container in a designated radioactive working area. Step 2. Thaw the Active HER2, Kinase Assay Buffer, Substrate and Enzyme Dilution Buffer on ice. Step 3. In a pre-cooled microfuge tube, add the following reaction components bringing the initial reaction volume up to 20μl: Component 1. 10μl of diluted Active HER2. Component 2. 10μl of 1mg/ml stock solution of substrate Step 4. Set up the blank control as outlined in step 3, excluding the addition of the substrate. Replace the substrate with an equal volume of distilled H 2 O. Step 5. Initiate the reaction by the addition of 5μl [ 32 P]-ATP Assay Cocktail bringing the final volume up to 25μl and incubate the mixture in a water bath at 30 °C for 15 minutes. 0 30,000 60,000 90,000 120,000 0 100 200 300 400 500 Protein (ng) Activit y (c pm ) IN VITRO RESEARCH PURPOSES ONLY. NOT INTENDED FOR USE IN HUMAN OR ANIMALS. Step 6. After the 15 minute incubation period, terminate the reaction by spotting 20μl of the reaction mixture onto individual pre-cut strips of phosphocellulose P81 paper. Step 7. Air dry the pre-cut P81 strip and sequentially wash in a 1% phosphoric acid solution (dilute 10ml of phosphoric acid and make a 1L solution with distilled H 2 O) with constant gentle stirring. It is recommended that the strips be washed a total of 3 intervals for approximately 10 minutes each. Step 8. Count the radioactivity on the P81 paper in the presence of scintillation fluid in a scintillation counter. Step 9. Determine the corrected cpm by removing the blank control value (see Step 4) for each sample and calculate the kinase specific activity as outlined below. Calculation of [P 32 ]-ATP Specific Activity (SA) (cpm/pmol) Specific activity (SA) = cpm for 5μl [ 32 P]-ATP / pmoles of ATP (in 5μl of a 250μM ATP stock solution, i.e., 1250 pmoles) Kinase Specific Activity (SA) (pmol/min/μg or nmol/min/mg) Corrected cpm from reaction / [(SA of 32 P-ATP in cpm/pmol)*(Reaction time in min)*(Enzyme amount in μg or mg)]*[(Reaction Volume) / (Spot Volume)]

Reinheit: >90%

Buffer: Recombinant protein stored in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 0.25mM DTT, 0.1mM EGTA, 0.1mM EDTA, 0.1mM PMSF, 25% glycerol.

Lagerung: Store at -80°C

Beschränkungen: Nur für Forschungszwecke einsetzbar